Gene · 7306
Papers3,635
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 3,635
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Instigation of the epoch of nanovaccines in cancer immunotherapy. | Wiley Interdiscip Rev Nanomed Nanobiotechnol | 2023 | 36410742 | PubTator, text mining | PubMed |
| Class 1 integron and related antimicrobial resistance gene dynamics along a complex freshwater system affected by different anthropogenic pressures. | Environ Pollut | 2023 | 36351483 | PubTator, text mining | PubMed |
| Epigenetic and pharmacological control of pigmentation via Bromodomain Protein 9 (BRD9). | Pigment Cell Melanoma Res | 2023 | 36112085 | PubTator, text mining | PubMed |
| Discovery, classification, evolution and diversity of Siglecs. | Mol Aspects Med | 2023 | 35989204 | PubTator, text mining | PubMed |
| Clinical and molecular change induced by repeated low-dose visible light exposure in both light-skinned and dark-skinned individuals. | Photodermatol Photoimmunol Photomed | 2023 | 35861041 | PubTator, text mining | PubMed |
| Cancer vaccine strategies using self-replicating RNA viral platforms. | Cancer Gene Ther | 2023 | 35821284 | PubTator, text mining | PubMed |
| TYRP1 Protects Against the Apoptosis and Oxidative Stress of Retinal Ganglion Cells by Binding to PMEL. | Ocul Immunol Inflamm | 2023 | 35708352 | PubTator, text mining | PubMed |
| Lactate modulates microglia polarization via IGFBP6 expression and remodels tumor microenvironment in glioblastoma. | Cancer Immunol Immunother | 2023 | 35654889 | PubTator, text mining | PubMed |
| Adiponectin negatively regulates pigmentation, Wnt/β-catenin and HGF/c-Met signalling within human scalp hair follicles ex vivo. | Arch Dermatol Res | 2023 | 34854998 | PubTator, text mining | PubMed |
| IgE reactivity patterns in Asian and central European cockroach-sensitized patients reveal differences in primary sensitizing allergen sources. | J Allergy Clin Immunol Glob | 2022 | 37781268 | PubTator, text mining | PubMed |
| Recent advances in overcoming barriers to cell-based delivery systems for cancer immunotherapy. | Exploration (Beijing) | 2022 | 37323702 | PubTator, text mining | PubMed |
| Reversal of Premature Hair Graying Treated with a Topical Formulation Containing α-Melanocyte-Stimulating Hormone Agonist (Greyverse Solution 2%). | Int J Trichology | 2022 | 37034550 | PubTator, text mining | PubMed |
| Melanogenesis and Hypopigmentation: The Case of Vitiligo. | Indian J Dermatol | 2022 | 36865864 | PubTator, text mining | PubMed |
| Recent development of hydrogen sulfide-releasing biomaterials as novel therapies: a narrative review. | Biomater Transl | 2022 | 36846507 | PubTator, text mining | PubMed |
| New panel of biomarkers to discriminate between amelanotic and melanotic metastatic melanoma. | Front Oncol | 2022 | 36776379 | PubTator, text mining | PubMed |
| A cis-regulatory lexicon of DNA motif combinations mediating cell-type-specific gene regulation. | Cell Genom | 2022 | 36742369 | PubTator, text mining | PubMed |
| Peripheral Blood of Vitiligo Patients-Derived Exosomal MiR-21-5p Inhibits Melanocytes Melanogenesis via Targeting SATB1. | Iran J Public Health | 2022 | 36742227 | PubTator, text mining | PubMed |
| MAPK inhibitors dynamically affect melanoma release of immune NKG2D-ligands, as soluble protein and extracellular vesicle-associated. | Front Cell Dev Biol | 2022 | 36726591 | PubTator, text mining | PubMed |
| Extracellular vesicles and melanoma: New perspectives on tumor microenvironment and metastasis. | Front Cell Dev Biol | 2022 | 36704194 | PubTator, text mining | PubMed |
| The Potential of Purple Waxy Corn Cob (Zea mays L.) Extract Loaded-Sericin Hydrogel for Anti-Hyperpigmentation, UV Protection and Anti-Aging Properties as Topical Product Applications. | Pharmaceuticals (Basel) | 2022 | 36678532 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7306/papers?page=22